Compounded Semaglutide: The 2026 Complete Guide
Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy under a physician prescription. It is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. It is most commonly used for chronic weight management in adults. This 2026 guide explains how it works, what it costs, whether it is safe, how it is regulated, and how to access it legally through US telehealth.
Last reviewed: 2026-05-31. Updated quarterly or when clinical guidance materially changes.
On this page
- 1. What is compounded semaglutide?
- 2. FDA-approval status and regulation
- 3. How it works (mechanism)
- 4. Cost breakdown in 2026
- 5. Is it safe?
- 6. Is it legal in the US?
- 7. Who is a candidate
- 8. How to get it online
- 9. Provider red flags
- 10. Dosing schedule
- 11. Side effects
- 12. Other GLP-1 options
- 13. Frequently asked questions
- 14. Sources
1. What is compounded semaglutide?
Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy under a prescription written by a licensed physician for an individual patient. This patient-specific compounding is governed by Section 503A of the Federal Food, Drug, and Cosmetic Act. A separate section of the law, 503B, covers FDA-registered outsourcing facilities, which operate under a different framework and are not required to compound against patient-specific prescriptions; that framework does not apply to the patient-specific model described here.
Compounded semaglutide is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. Compounded preparations have not been the subject of their own clinical trials; the dose, the plan, and realistic expectations are set by the prescribing physician, and individual results vary.
Plain-English summary
Compounded semaglutide is a preparation that contains semaglutide, made by a licensed compounding pharmacy and prescribed by a physician for an individual patient. It is not FDA-approved as a final product and is not a generic version of any FDA-approved medication.
2. FDA-approval status: what compounding means legally
FDA approval applies to a specific finished drug product made by a specific manufacturer: its formulation, manufacturing process, labeling, and clinical trial evidence are reviewed and approved as a package. Compounded medications sit in a different legal category. They are prepared by a state-licensed compounding pharmacy for an individual patient under a physician prescription, as permitted by Section 503A of the Federal Food, Drug, and Cosmetic Act, and the finished preparation itself is not reviewed or approved by the FDA.
Three practical consequences follow. First, compounded semaglutide is not FDA-approved as a final product. Second, it is not a generic: a generic drug goes through its own FDA review demonstrating equivalence to a reference product, and no compounded preparation does that. Third, it is not equivalent to or interchangeable with any FDA-approved medication, and clinical trial results generated by FDA-approved products do not describe compounded preparations.
Oversight of compounding comes from state boards of pharmacy, which license and inspect compounding pharmacies, and from United States Pharmacopeia standards (USP 795 and 797) that govern how preparations are made. For the Section 503A patient-specific model described on this page, a valid prescription from a licensed physician for an identified individual patient is required.
Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers, which are not affiliated with and do not endorse Majesta Health. Those are separate FDA-approved products that we do not sell, and they are named here only to make that distinction clear. Results may vary. Not a substitute for professional medical advice.
3. How compounded semaglutide works
Semaglutide is a GLP-1 receptor agonist. It mimics glucagon-like peptide-1, a hormone the gut releases in response to food, and it acts on three systems that drive appetite, eating behavior, and glycemic control:
- Slows gastric emptying. Food remains in the stomach longer, increasing satiety per meal.
- Suppresses appetite at the hypothalamus. Reduces the drive to seek food between meals.
- Improves insulin secretion in response to glucose. Helps control post-meal glucose spikes.
The result is reduced caloric intake without active willpower work, alongside better post-meal blood sugar control. No clinical trials have been conducted on compounded semaglutide itself, so we do not quote efficacy figures for it. Your prescribing physician sets the dose and realistic expectations for your case, and outcomes in real world practice vary based on dose, adherence, diet, activity, and other medical factors.
4. Compounded semaglutide cost in 2026
At Majesta Health, compounded semaglutide injection (the Essential plan) is $179 your first month, then $299 a month. One price includes the physician consultation, the medication, and shipping. A $20 medical consultation fee is included in your first month, collected on a pass-through basis to the prescribing provider where applicable. Cancel anytime.
Flagship plan
Essential
Compounded semaglutide injection
$179 first month
Then $299 per month
See Essential detailsTirzepatide
Performance
Compounded tirzepatide injection
$339 first month
Then $439 per month
See Performance detailsBoth plans include physician consultation, compounded medication, discreet shipping, and unlimited messaging with your care team. Cancel anytime.
What is actually in your monthly price?
- Physician evaluation and ongoing care
- Compounded medication from a US-licensed compounding pharmacy
- Discreet, temperature-controlled shipping
- Unlimited messaging with the care team
- A $20 medical consultation fee where applicable, collected on a pass-through basis to the prescribing physician
For a deeper cost breakdown, including hidden fees to watch for at other providers, read our full compounded semaglutide cost guide.
5. Is compounded semaglutide safe?
Compounded semaglutide prepared by a properly licensed and inspected pharmacy uses an active pharmaceutical ingredient that meets United States Pharmacopeia standards. Compounded semaglutide is not FDA-approved as a final product and is not interchangeable with any FDA-approved medication. Safety in practice depends on three independent things: pharmacy quality, physician evaluation, and honest patient disclosure.
What good pharmacy quality looks like
- Active state pharmacy license
- LegitScript pharmacy certification or NABP accreditation, verifiable in their public registries
- Compliance with USP 795 (non-sterile compounding), USP 797 (sterile compounding), USP 800 (hazardous drugs) where applicable
- active ingredient sourcing to USP standards
- Clean recent state Board of Pharmacy inspection history
What good physician evaluation looks like
- Reviews complete medical history, current medications, and goals before writing a prescription
- Screens for contraindications including medullary thyroid carcinoma history, MEN 2, pancreatitis, type 1 diabetes, pregnancy and conception plans, and severe gastrointestinal disease
- Holds a license in the patient's state of residence
- Provides ongoing care, not a one-time evaluation
- Has clear escalation paths for adverse events
6. Is compounded semaglutide legal in the United States?
Yes, when properly prescribed and dispensed under the federal compounding framework. Pharmacy compounding in the United States is governed by:
- Section 503A of the Federal Food, Drug, and Cosmetic Act. Permits compounding by a state-licensed pharmacist for an identified individual patient based on a valid prescription.
- Section 503B of the Federal Food, Drug, and Cosmetic Act. A separate framework for FDA-registered outsourcing facilities, which compound at larger scale and are not required to work from patient-specific prescriptions. It is distinct from the 503A patient-specific model described on this page.
- State Boards of Pharmacy. License and inspect compounding pharmacies operating within each state.
- State medical boards and the Ryan Haight Act. Govern telehealth prescribing, including the requirement that prescribers be licensed in the patient's state.
What is not allowed: copying an FDA-approved drug solely because it is cheaper or more convenient. The FDA has clarified that compounding is appropriate when a clinical need exists for an individual patient that cannot be met by the FDA-approved product, including documented allergies, dosing needs, formulation differences (such as sublingual delivery), and documented availability concerns.
Majesta Health works exclusively with US-licensed physicians (through MD Integrations, our telehealth provider group partner) and state-licensed 503A compounding pharmacy partners. The pharmacy that prepares your prescription is named on your prescription label and disclosed before your medication ships.
7. Who is a candidate for compounded semaglutide?
The candidacy question is decided by a licensed physician based on your complete medical history. The general clinical pattern, drawn from FDA labeling and major trials, is:
Typically appropriate for evaluation
- Adults with a BMI of 30 or higher
- Adults with a BMI of 27 or higher and at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea
- Patients who have not achieved their goals with diet and lifestyle alone
Typically not appropriate
- Personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2)
- History of severe hypersensitivity to semaglutide
- Active pancreatitis
- Type 1 diabetes
- Active pregnancy, attempts to conceive, or breastfeeding
- Eating disorders (active or history)
- Under 18 years of age
People with diabetic retinopathy, history of severe gastrointestinal disease, moderate to severe kidney impairment, or any complex medication regimen require careful physician evaluation before starting. Always disclose your full medical history and every medication and supplement during your assessment.
8. How to get compounded semaglutide online
US telehealth platforms have streamlined the path significantly. At Majesta Health, the standard flow is five steps:
Step 1
Complete a 2-minute medical assessment
Confirm your state, goals, and medical history. Mississippi and Louisiana residents are routed to a waitlist because our clinician network does not currently serve those states.
Step 2
Consent to telehealth services
Review and accept our telehealth informed consent. This is a required step before any clinical evaluation.
Step 3
Physician review
A US-licensed physician from MD Integrations, our telehealth provider group partner, reviews your file. Where your state's telehealth rules require it, or where the physician decides it is needed, your evaluation also includes a phone or video visit. If you are a candidate, they write the prescription. If you are not, they explain why and refer you to alternatives.
Step 4
Pharmacy fills your prescription
Our partner state-licensed compounding pharmacy prepares your monthly supply.
Step 5
Discreet shipping and ongoing care
Temperature-controlled shipping to your door. Unlimited messaging with the care team for questions, dose adjustments, and side effect support.
For a deeper walkthrough including what to expect at each step, read our online GLP-1 prescription guide.
9. Compounded semaglutide provider red flags
The compounded GLP-1 market grew quickly between 2022 and 2025. Most providers are legitimate. Some are not. Walk away from any provider that does one of the following:
- Promises specific pounds lost or specific clothing sizes
- Ships medication without a physician evaluation, or claims no prescription is required
- Markets the medication as FDA-approved, or hides the compounded status
- Does not name its partner compounding pharmacy or refuses to confirm its state licensure
- Uses fake before-and-after photos or testimonials that look stock or copied from other sites
- Prices that are far below the market range without a transparent explanation, especially below $99 per month for injectable semaglutide
- No physical business address, no phone number, and no clear ownership disclosure
- Pressures one-click upsells before a physician has even reviewed your case
10. Compounded semaglutide dosing schedule
The prescribing clinician determines the formulation, dose, and titration schedule for each patient. Dosing may vary by formulation and dispensing pharmacy. Patients should follow only the prescription label and clinician instructions and should not change the dose without medical guidance.
Do not change your dose without talking to your physician. Skipping doses or doubling up to catch up creates unnecessary side effects without improving outcomes.
11. Side effects of compounded semaglutide
The most commonly reported side effects of semaglutide are gastrointestinal and tend to peak during dose escalation and improve over weeks.
Common (typical of dose increases)
- Nausea (most common)
- Vomiting
- Diarrhea or constipation
- Decreased appetite (intended effect)
- Mild fatigue
- Headache
- Reflux or abdominal discomfort
Less common but more serious
- Pancreatitis (severe abdominal pain that radiates to the back)
- Gallbladder disease, including gallstones
- Severe hypoglycemia, especially in patients also taking insulin or sulfonylureas
- Acute kidney injury from dehydration
- Allergic reactions
- Changes in diabetic retinopathy in patients with that condition
Contact your prescribing physician for symptoms that persist beyond expected adjustment windows or that are severe. Seek emergency care for symptoms suggesting pancreatitis, severe allergic reaction, severe dehydration, or severe hypoglycemia. For practical management tips, see our semaglutide side effects guide.
12. Compounded semaglutide vs other GLP-1 options
Compounded semaglutide is one of several GLP-1 options patients consider in 2026. The two most common comparisons:
Sublingual semaglutide
A daily oral troche that dissolves under the tongue, offered by some other providers. Majesta Health does not offer a sublingual formulation: published data on sublingual absorption is limited, and the injectable route is the one used in all major clinical trials. Visit our GLP-1 hub for how these options fit together.
Compounded tirzepatide
Compounded tirzepatide contains tirzepatide, a dual GIP and GLP-1 receptor agonist, meaning it acts on two gut hormone pathways instead of one. It is available through some US telehealth providers and is typically priced higher than compounded semaglutide. At Majesta Health it is offered as the Performance plan; the full picture is in our compounded tirzepatide 2026 guide.
13. Frequently asked questions
What is compounded semaglutide?
Compounded semaglutide is a preparation that contains semaglutide, made by a state-licensed compounding pharmacy based on a prescription written by a licensed physician for an individual patient. The finished compounded preparation is not FDA-approved as a final product and is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. This not-FDA-approved status applies to all properly compounded medications under Section 503A of the Federal Food, Drug, and Cosmetic Act.
How much does compounded semaglutide cost in 2026?
At Majesta Health, the semaglutide injection plan (Essential) is $179 your first month and $299 a month after. One price includes the physician consultation, the medication, and shipping. A $20 medical consultation fee is included in your first month, collected on a pass-through basis to the prescribing physician. Cancel anytime.
Is compounded semaglutide safe?
Compounded semaglutide prepared by a properly licensed and inspected compounding pharmacy uses an active pharmaceutical ingredient and follows United States Pharmacopeia standards (USP 795, 797, 800 as applicable). Safety depends on three things: the pharmacy's licensure and inspection record, the prescribing physician's evaluation of your medical history, and your honest reporting of conditions and medications. Commonly reported side effects of semaglutide include nausea, decreased appetite, fatigue, and gastrointestinal discomfort. Always disclose pregnancy plans, personal or family history of medullary thyroid cancer or MEN 2, pancreatitis, and any GLP-1 medications you have taken in the past.
Is compounded semaglutide FDA-approved?
No compounded medication is FDA-approved as a final product, and compounded semaglutide is not a generic version of, equivalent to, or interchangeable with any FDA-approved medication. Properly compounded preparations are produced legally under Section 503A of the Federal Food, Drug, and Cosmetic Act when prepared for an individual patient based on a prescription from a licensed physician.
How do I get compounded semaglutide online?
Through licensed telehealth platforms, the typical flow is: complete an online medical assessment, consent to telehealth services, have your file reviewed by a US-licensed physician in your state, fill a prescription at a partner compounding pharmacy, and receive monthly shipments to your door. At Majesta Health, the assessment takes about two minutes and you only proceed if your file qualifies you for care.
How long does it take to see results with compounded semaglutide?
Appetite changes are commonly reported early in treatment, during the titration phase, and your physician monitors your progress from there. No clinical trial has measured a results timeline for the compounded preparation, so we do not project one and continue through months six to twelve as the maintenance dose is reached. Compounded semaglutide has not been the subject of its own clinical trials; your physician sets the dose and realistic expectations for your case. Individual results vary based on dose, adherence, diet, activity level, and other medical factors.
What is the dosing schedule for compounded semaglutide?
The prescribing clinician determines the formulation, dose, and titration schedule for each patient. Dosing may vary by formulation and dispensing pharmacy. Patients should follow only the prescription label and clinician instructions and should not change the dose without medical guidance.
Who should not take compounded semaglutide?
Semaglutide is not appropriate for people with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2 (MEN 2), known severe hypersensitivity to semaglutide, active pancreatitis, type 1 diabetes, current pregnancy or active attempts to conceive, or breastfeeding. People with a history of severe gastrointestinal disease, diabetic retinopathy, or moderate to severe kidney impairment require careful physician evaluation before starting. Always disclose your full medical and medication history during the assessment.
What are the most common side effects of compounded semaglutide?
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, abdominal pain, and decreased appetite. These tend to be strongest during dose escalation and improve over weeks. Less common but more serious side effects include pancreatitis, gallbladder problems, severe hypoglycemia (especially in people also taking insulin or sulfonylureas), kidney injury from dehydration, allergic reactions, and changes in diabetic retinopathy. Contact your provider for symptoms that do not improve or are severe.
Can I stop compounded semaglutide once I reach my goal?
Stopping any GLP-1 medication abruptly often leads to appetite return and, for many people, partial weight regain over time. That is why discontinuation should be a plan, not an event. A licensed physician can help you build a maintenance plan, which may include reduced dosing, monitored discontinuation, lifestyle support, or transition to a long-term plan based on your goals.
Is compounded semaglutide covered by insurance?
Compounded medications are generally paid out of pocket and not covered by commercial insurance plans. HSA and FSA accounts can usually be used for the medical consultation portion when prescribed by a licensed physician for a covered condition. Confirm with your plan administrator.
What is the difference between sublingual and injectable compounded semaglutide?
Injectable semaglutide is administered subcutaneously once per week and is the dosing form used in all major clinical trials. Sublingual semaglutide is a compounded oral troche that dissolves under the tongue, offered by some other providers. Majesta Health offers the injectable form only: published data on sublingual absorption is limited, and the injectable route is the one used in all major clinical trials.
Can I take compounded semaglutide with other weight loss medications?
Combining GLP-1 medications with other weight loss drugs, supplements, or other GLP-1 medications is not appropriate without explicit physician guidance because of overlapping mechanisms and increased risk of low blood sugar, dehydration, and gastrointestinal side effects. Disclose every medication and supplement you take during your assessment.
How is compounded semaglutide shipped and stored?
Injectable compounded semaglutide ships in temperature-controlled packaging and is typically stored refrigerated between 36 and 46 degrees Fahrenheit. Follow the storage instructions on the pharmacy label, which take precedence over general guidance.
How do I know a compounded semaglutide provider is legitimate?
Look for these signals: a named US-licensed physician network, a named partner compounding pharmacy licensed in your state, transparent pricing and disclosure language, a written telehealth informed consent, clear medical assessment with state restriction enforcement, no specific weight loss guarantees, no fake testimonials, and a real physical business address. Avoid providers that promise specific weight loss, ship without a physician evaluation, or advertise prices that look impossibly low.
14. Sources and references
- FDA, Compounding and the FDA: Questions and Answers
- FDA, Section 503A of the Federal Food, Drug, and Cosmetic Act
- USP, General Chapters 795, 797, 800 (compounding standards)
This guide reflects publicly available information as of 2026-05-31. It is educational and does not substitute for personalized medical advice. Compounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers, which are not affiliated with and do not endorse Majesta Health. Those are separate FDA-approved products that we do not sell, and they are named here only to make that distinction clear. Results may vary. Not a substitute for professional medical advice.
Continue reading
Deeper guides on cost, safety, comparisons, and access.
Reserve your founding-member spot
Founding members get priority access, locked-in pricing, and a dedicated US-licensed physician when we open.
Start Your AssessmentCompounded medications are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any FDA-approved medication. Compounded GLP-1 medications are prepared by state-licensed compounding pharmacies based on a physician's prescription for an individual patient. Ozempic®, Wegovy®, Mounjaro®, and Zepbound® are registered trademarks of their respective manufacturers, which are not affiliated with and do not endorse Majesta Health. Those are separate FDA-approved products that we do not sell, and they are named here only to make that distinction clear. Results may vary. Not a substitute for professional medical advice.